Emergent Biosolutions EBS Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from Emergent Biosolutions’s reported figures.
Based on trailing twelve months.
The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's gross margin?
- Emergent Biosolutions (EBS) reported gross margin of 54.2% in Q1 2026.
- How has Emergent Biosolutions's gross margin changed year-over-year?
- Emergent Biosolutions's gross margin increased by 53.9% year-over-year, from 35.2% to 54.2%.
- What is the long-term trend for Emergent Biosolutions's gross margin?
- Over 4 years (2020 to 2025), Emergent Biosolutions's gross margin has grown at a -4.3% compound annual growth rate (CAGR), from 66.9% to 56.1%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.